Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Terns Pharmaceuticals Q2 EPS $(0.43) Up From $(33.09) YoY

Terns Pharmaceuticals (NASDAQ:TERN) reported quarterly losses of $(0.43) per share. This is a 98.7 percent increase over losses of $(33.09) per share from the same period last year.
byBill Haddad
August 16, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Terns Pharmaceuticals (NASDAQ:TERN) reported quarterly losses of $(0.43) per share. This is a 98.7 percent increase over losses of $(33.09) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts